240 related articles for article (PubMed ID: 29194686)
1. New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases.
Win S; Than TA; Zhang J; Oo C; Min RWM; Kaplowitz N
Hepatology; 2018 May; 67(5):2013-2024. PubMed ID: 29194686
[TBL] [Abstract][Full Text] [Related]
2. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.
Seki E; Brenner DA; Karin M
Gastroenterology; 2012 Aug; 143(2):307-20. PubMed ID: 22705006
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium selenite on c-Jun N-terminal kinase signalling pathway induced by oxidative stress in human chondrocytes and c-Jun N-terminal kinase expression in patients with Kashin-Beck disease, an endemic osteoarthritis.
Dai X; Li Y; Zhang R; Kou Y; Mo X; Cao J; Xiong Y
Br J Nutr; 2016 May; 115(9):1547-55. PubMed ID: 26948765
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells.
Su JL; Lin MT; Hong CC; Chang CC; Shiah SG; Wu CW; Chen ST; Chau YP; Kuo ML
Carcinogenesis; 2005 Jan; 26(1):1-10. PubMed ID: 15217905
[TBL] [Abstract][Full Text] [Related]
5. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
6. Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts.
Park EJ; Zhao YZ; Kim YC; Sohn DH
Eur J Pharmacol; 2007 Mar; 559(2-3):115-23. PubMed ID: 17292878
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
[TBL] [Abstract][Full Text] [Related]
8. Scaffold Role of DUSP22 in ASK1-MKK7-JNK Signaling Pathway.
Ju A; Cho YC; Kim BR; Park SG; Kim JH; Kim K; Lee J; Park BC; Cho S
PLoS One; 2016; 11(10):e0164259. PubMed ID: 27711255
[TBL] [Abstract][Full Text] [Related]
9. JNK pathway: diseases and therapeutic potential.
Cui J; Zhang M; Zhang YQ; Xu ZH
Acta Pharmacol Sin; 2007 May; 28(5):601-8. PubMed ID: 17439715
[TBL] [Abstract][Full Text] [Related]
10. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
11. Wallenda regulates JNK-mediated cell death in Drosophila.
Ma X; Xu W; Zhang D; Yang Y; Li W; Xue L
Cell Death Dis; 2015 May; 6(5):e1737. PubMed ID: 25950467
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
Mhaidat NM; Zhang XD; Jiang CC; Hersey P
Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.
Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ
Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820
[TBL] [Abstract][Full Text] [Related]
14. C-Jun N-terminal kinase signalling pathway in response to cisplatin.
Yan D; An G; Kuo MT
J Cell Mol Med; 2016 Nov; 20(11):2013-2019. PubMed ID: 27374471
[TBL] [Abstract][Full Text] [Related]
15. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
16. The JNK signal transduction pathway.
Weston CR; Davis RJ
Curr Opin Cell Biol; 2007 Apr; 19(2):142-9. PubMed ID: 17303404
[TBL] [Abstract][Full Text] [Related]
17. Antcin H Protects Against Acute Liver Injury Through Disruption of the Interaction of c-Jun-N-Terminal Kinase with Mitochondria.
Huo Y; Win S; Than TA; Yin S; Ye M; Hu H; Kaplowitz N
Antioxid Redox Signal; 2017 Feb; 26(5):207-220. PubMed ID: 27596680
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.
Nakagawa H; Hirata Y; Takeda K; Hayakawa Y; Sato T; Kinoshita H; Sakamoto K; Nakata W; Hikiba Y; Omata M; Yoshida H; Koike K; Ichijo H; Maeda S
Hepatology; 2011 Jul; 54(1):185-95. PubMed ID: 21488081
[TBL] [Abstract][Full Text] [Related]
19. Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.
Wang J; Tai G
Target Oncol; 2016 Dec; 11(6):723-738. PubMed ID: 27392951
[TBL] [Abstract][Full Text] [Related]
20. Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.
Wang YD; Chen WD; Li C; Guo C; Li Y; Qi H; Shen H; Kong J; Long X; Yuan F; Wang X; Huang W
Mol Endocrinol; 2015 Feb; 29(2):322-31. PubMed ID: 25496033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
